Maximus (NYSE:MMS) Stock Rating Lowered by StockNews.com

Maximus (NYSE:MMS) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Friday.

Separately, Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a report on Thursday, January 2nd.

Maximus Stock Performance

Shares of Maximus stock opened at $67.69 on Friday. The company has a market cap of $3.87 billion, a P/E ratio of 14.56 and a beta of 0.72. The business has a 50-day moving average price of $74.12 and a two-hundred day moving average price of $82.48. The company has a current ratio of 1.72, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82. Maximus has a 1-year low of $66.52 and a 1-year high of $93.97.

Maximus (NYSE:MMS) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, analysts anticipate that Maximus will post 6.05 EPS for the current year.

Insider Buying and Selling

In other news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now owns 6,567 shares of the company’s stock, valued at $484,841.61. This represents a 25.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bruce Caswell purchased 3,500 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, with a total value of $247,240.00. Following the purchase, the chief executive officer now directly owns 275,929 shares in the company, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 7,063 shares of company stock worth $502,017. 1.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Maximus

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. V Square Quantitative Management LLC purchased a new stake in shares of Maximus during the 3rd quarter valued at approximately $25,000. UMB Bank n.a. lifted its position in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after acquiring an additional 158 shares in the last quarter. Eastern Bank bought a new position in shares of Maximus in the fourth quarter worth $29,000. R Squared Ltd purchased a new position in shares of Maximus in the fourth quarter valued at $54,000. Finally, IFP Advisors Inc raised its stake in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the period. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.